Influenza is a disease that has caused the deaths of tens of millions people in the last century alone. The influenza neuraminidase protein is essential in the mechanism infection. It enables the virus to leave the infected cell and proliferate. Antiviral neuraminidase inhibitor drugs can be used for treatment. The drug Tamiflu is the standard of care for both treatment and prophylaxis of influenza. The Cochrane reports of 2009 and 2014 conclude that evidence is lacking to support this. Numerous bodies disagree. Cochrane also question the accuracy and credibility of many studies and agencies in support of Tamiflu. This paper explores the issues.
Hershkop, E. (2015). Is the Neuraminidase Inhibitor Tamiflu Effective in the Treatment of Influenza?. The Science Journal of the Lander College of Arts and Sciences, 9 (1). Retrieved from http://touroscholar.touro.edu/cgi/viewcontent.cgi?article=1036&context=sjlcas